| 1. |
Tanimoto K, Kato K, Aoki T, Yoshimoto G, Choi I, Kadowaki M, Sugio Y, Kuriyama T, Kawano N, , Suzuki R, Miyawaki K, Henzan H, Saito N, Ohta T, Miyamoto T, Akashi K., CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma, 63rd American Society of Hematology Annual Meeting and Exposition, 2021.12. |
| 2. |
Thieblemont C, Dickinson M, Martinez-Lopez J, Kolstad A, ButlerJP, Ghosh, M, Popplewell LL, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis Riedell PA, Ho PJ, Pérez-Simón J, Chen A, Nastoupil L, Tresckow B, Ferreri A, Teshima T, Patten Piers, Joseph P. McGuirk JP, Petzer A, Offner F, Viardot A, Zinzani Pl, Malladi R, Zia A, Bodoni CLi, , Masood A, Stephen JS, Fowler NH, Dreyling MH., Efficacy of Tisagenlecleucel in Adult Patients (Pts) with High-Risk Relapsed/Refractory Follicular Lymphoma (r/r FL): Subgroup Analysis of the Phase II Elara Study , 63rd American Society of Hematology Annual Meeting and Exposition, 2021.12. |
| 3. |
Nathan H Fowler, Michael Dickinson, Martin Dreyling, , Joaquin Martinez-Lopez, Arne Kolstad, , Jason P Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio C. Chavez, Emmanuel Bachy, , Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A. Riedell, P. Joy Ho, , D.Phil, Jose Antonio Pérez-Simón, Sarah J. Nagle, Loretta J. Nastoupil, Bastian von Tresckow, Andres JM Ferreri, Takanori Teshima, Piers Patten, Joseph P. McGuirk, Andreas Petzer Fritz Offner, MD, Andreas Viardot, , Pier Luigi Zinzani, Ram Malladi, Lida Bubuteishvili Pacaud, Alessandra Forcina, Aiesha Zia, Stephen J. Schuster, and Catherine Thieblemont., Efficacy and Safety of Tisagenlecleucel in Adult Patients with Relapsed/Refractory Follicular Lymphoma: Interim Analysis of the Phase 2 Elara Trial, 62nd American Society of Hematology Annual Meeting and Exposition, 2020.12. |
| 4. |
Koji Kato, Treatment approach for relapse after allo-HSCT in patients with adult T-cell leukemia/lymphoma., 第82回日本血液学会学術集会 シンポジウム Relapse After Allogeneic HSCT: Challenges and New Directions, 2020.10. |
| 5. |
Koji Kato, Tom Van Meerten, Roch Houot, Monique C. Minnema, Noel Milpied, Pieternella J. Lugtenburg, Catherine Thieblemont, Max S. Topp, Martin Wermke, Kevin W. Song, Irit Avivi, John Kuruvilla, Ulrich Duhrsen, Rong Chu, Lianqing Zheng, Vicki Plaks, Anne Kerber, Marie Jose Kersten, Earlier steroid use with axicabtagene ciloleucel in relapsed/refractory large B cell lymphoma, 第82回日本血液学会学術集会 , 2020.10. |
| 6. |
Kensuke Sasaki, Kohta Miyawaki, Yuichiro Semba, Koji Kato, Jumpei Nogami, Takeshi Sugio, , Toshihiro Miyamoto, Yoshikiyo Ito, Koji Nagafuji, Takahiro Maeda, Koichi Akashi, A Fast and Accurate Diagnostic Method for Ph-like ALL Using the Ncounter System, 61st annual meeting of the American society of hematology, 2019.12. |
| 7. |
Veronika Bachanova, Constantine S. Tam, Peter Borchmann, Ulrich Jaeger, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael R. Bishop, Charalambos Andreadis, Stephen Ronan Foley, Jason R. Westin, Isabelle Fleury, P Joy Ho, Stephan Mielke, Takanori Teshima, Gilles Salles, Stephen J Schuster, Richard T. Maziarz, Koen Van Besien, Koji Izutsu, Marie Jose Kersten, John M. Magenau, Nina D. Wagner-Johnston, Koji Kato, Paolo Corradini, Jufen Chu, Irina Gershgorin, Therese Choquette, Lida Bubuteishvili Pacaud, Margit Jeschke., Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL), 61st annual meeting of the American society of hematology, 2019.12. |
| 8. |
Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Masahito Tokunaga, Atsushi Wake, Nobuaki Nakano, Tetsuya Eto, Michihiro Hidaka, Ilseung Choi, Toshihiro Miyamoto, Naoyuki Uchida, Yukiyoshi Moriuchi, Yasuhiko Miyazaki, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Koji Kato., Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm, 61st annual meeting of the American society of hematology, 2019.12. |
| 9. |
Kohta Miyawaki, Takuji Yamauchi, Takeshi Sugio, Kensuke Sasaki, Hiroaki Miyoshi, Simon Osborne, Deborah Taylor, Koichi Ohshima, Koji Kato, Takahiro Maeda, Koichi Akashi., Paics Inhibition Is a Potential Therapeutic Strategy for MYC-Positive DLBCL, 61st annual meeting of the American society of hematology, 2019.12. |
| 10. |
Dai Maruyama, Kiyoshi Ando, Kazuhito Yamamoto, Eiji Kiyohara, Yasuhito Terui, Noriko Fukuhara, Tomomitsu Miyagaki, Hidetsugu Kawai, Yoshiki Tokura, Mamiko Sakata-Yanagimoto, Tadahiko Igarashi, Junya Kuroda, Jiro Fujita, Toshiki Uchida, Takayuki Ishikawa, Kentaro Yonekura, Koji Kato, Tadashi Nakanishi, Kenya Nakai, Risa Matsunaga, Kensei Tobinai., Phase 2 Study of E7777, a Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein, in Japanese Patients with Relapsed or Refractory Peripheral and Cutaneous T-Cell Lymphoma, 61st annual meeting of the American society of hematology, 2019.12. |
| 11. |
Charalambos Andreadis, Constantine S. Tam, Peter Borchmann, Ulrich Jaeger, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael R. Bishop, MD,Stephen Ronan Foley, Jason R. Westin, Isabelle Fleury, P Joy Ho, Stephan Mielke, Takanori Teshima, Gilles A. Salles, Stephen J Schuster, Veronika Bachanova, Richard T. Maziarz, Koen Van Besien, Koji Izutsu, John M. Magenau, Nina D. Wagner-Johnston, Koji Kato, Paolo Corradini, Ranjan Tiwari, Rakesh Awasthi, Tomasz Lawniczek, Lamis K. Eldjerou, Marie Jose Kersten., Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel, 61st annual meeting of the American society of hematology, 2019.12. |
| 12. |
Jason R. Westin, Constantine S. Tam, Peter Borchmann, Ulrich Jaeger, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael R. Bishop, Charalambos Andreadis, Stephen Ronan Foley, Isabelle Fleury, P Joy Ho, Stephan Mielke, Takanori Teshima, Stephen J Schuster, Veronika Bachanova, Richard T. Maziarz, Koen Van Besien, Koji Izutsu, Marie Jose Kersten, John M. Magenau, Nina D. Wagner-Johnston, Koji Kato, Paolo Corradini, Xia Han, Ranjan Tiwari, Sergei Agoulnik, Lamis K. Eldjerou, Lida Bubuteishvili Pacaud, Gilles A. Salles., Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial, 61st annual meeting of the American society of hematology, 2019.12. |
| 13. |
Koji Kato, A germinal center-associated microenvironmental signature predicts clinical outcome of diffuse large B-cell lymphoma, The 10th JSH International Symposium 2019 JSH/EHA Joint Session Normal & Pathologic B Cells, 2019.05. |
| 14. |
加藤 光次，山本 一仁，石川 隆之，Kathryn Humphrey，Su Young Kim，大久保 澄子，伊豆津 宏二, Phase 2 study of venetoclax combined with rituximab in Japanese patients with relapsed/refractory chronic lymphocytic leukemia, The 10th JSH International Symposium 2019 , 2019.05. |
| 15. |
Stephen J. Schuster, Michael R. Bishop, Constantine Tam, Peter Borchmann, Ulrich Jaeger, Edmund K. Waller, Harald Holte, Joseph P. McGuirk, Samantha Jaglowski, Kensei Tobinai, Charalambos Andreadis, Isabelle Fleury, Stephan Mielke, Takanori Teshima, Jason R. Westin, Veronika Bachanova, Stephen Ronan Foley, P Joy Ho, John M. Magenau, Nina D. Wagner-Johnston, Koji Kato, Marie Jose Kersten, Koen Van Besien, Jufen Chu, Aline Jary, Özlem Anak, Gilles Salles and Richard Thomas T. Maziarz, Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel, 60th American Society of Hematology Annual Meeting and Exposition, 2018.12. |
| 16. |
Koji Kato, B-cell signaling inhibitiors in DLBCL, Hematologic Malignacies Summit, 2018.04. |
| 17. |
Koji Kato, Immunotherapy in SCT: The role of immunotherapy in patients with adult T-cell leukemia/lymphoma , 第40回日本造血幹細胞移植学会総会, 2018.02. |
| 18. |
Takeshi Sugio, Kohta Miyawaki, Koji Kato, Kensuke Sasaki, Hiroaki Miyoshi, Takahiro Maeda, Koichi Ohshima, Koichi Akashi, Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification and Therapeutic Strategy in Peripheral T-Cell Lymphoma., 59th annual meeting of the American society of hematology, 2017.12. |
| 19. |
Kohta Miyawaki, Takeshi Sugio, Koji Kato, Kensuke Sasaki, Hiroaki Miyoshi, Jon C. Aster, Frank C. Kuo, Koichi Ohshima, Takahiro Maeda, Koichi Akashi, Lymphoma Microenvironment Signature Predicts Clinical Outcomes in Diffuse Large B-cell Lymphoma Patients, 59th annual meeting of the American society of hematology, 2017.12. |
| 20. |
加藤光次, Focusing on the treatment of R/R HL, Takeda Lymphoma Seminar at ICML 2017, 2017.06. |
| 21. |
Sugio T, Miyawaki K, Kato K, MIyoshi H, Oshima K, Akashi K., Delineation of novel subtypes based on microenvironment immune signature provides prognostic stratification strategy in peripheral T-cell lymphoma, 8th JSH International Symposium, 2017.05. |
| 22. |
Sugio T, Miyawaki K, Kato K, Miyoshi H, Ohshima K, Akashi K, Delineation of Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification Strategy in Peripheral T-Cell Lymphoma, 58th annual meeting of the American society of hematology, 2016.12. |
| 23. |
Ogura M, Maruyama D, Tobinai K, Uchida T, Hatake K, Taniwaki M, Ando K, Tsukasaki K, Ishida T, Kobayashi N, Ishizawa K, Tatsumi Y, Kato K, Kiguchi T, Ikezoe T, Laille E, Ro T, Tamakoshi H, Sakurai S, Ohtsu T, Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma , 58th annual meeting of the American society of hematology, 2016.12. |
| 24. |
Jinnouchi F, Takenaka K, Iwamoto C, Yamauchi T, Yurino A, Nunomura T, Kikushige Y, Kato K, Miyamoto T, Akashi K, Introduction of Macrophage Tolerance By Human SIRPA Knock-in Enhances Peripheral Reconstitution of Human Hematopoiesis in Xenotransplantation Model, 58th annual meeting of the American society of hematology, 2016.12. |
| 25. |
Dlouhy I, Karube K, Enjuanes A, Martín-García D, Nadeu F, Ordoñez RG, Rovira J, Royo C, Navarro A, Gonzalez B, Castellano G, Rubio-Perez C, Tamborero D, Briones J, Salar A, Sancho JM, Mercadal S, Barca EG, Escoda L, Hiroaki M, Ohshima K, Kato K, Akashi K, Mozos A, Colomo L, Alcoceba M, Valera A, Carrio A, Lopez-Bigas N, Schmitz R, Staudt L, Jares P, Salaverria I, López-Guillermo A, Campo E, Delineation of Novel Subtypes Based on Microenvironment Immune Signature Integrating Genomic Alterations in Diffuse Large B-Cell Lymphoma Identifies New Relevant Pathways and Potential Therapeutic Targets, 58th annual meeting of the American society of hematology, 2016.12. |
| 26. |
Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, Mori Y, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Ogawa R, Ohno Y, Eto T, Kamimura T, Miyamoto T, Akashi K., Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease, 7th JSH International Symposium, 2016.05. |
| 27. |
Yakushijin K, Ikezoe T, Ohwada C, Kudo K, Okamura H, Goto H, Yabe H, Yasumoto A,Kuwabara H, Fujii S, Kagawa K, Ikebe T, Onishi Y, Morishita1 Y, Watamoto K, Uoshima N, Nakamura D, Ota S, Ueda Y, Oyake T, Koike K, Mizuno I, Iida H, Katayama Y, Hiroatsu A, Kato K, Okamura A, Kikuta A, Fukuda T., Nationwide Survey of Defbrotide and Recombinant Human Soluble Thrombomodulin for Treatment of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation, 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, 2016.04. |
| 28. |
Yoshimoto G, Kato K, Mori Y, Miyamoto T, Kamezaki K, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, Allogenic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Induction Failure, 2016 BMT Tandem Meetings, 2016.02. |
| 29. |
Miyoshi H, Kiyasu J, Kato T, Yoshida N, Kurita D, Yuya S, Kato K, Imaizumi Y, Seto M, Akashi K, Ohshima K, Immunohistochemical Expression Pattern of Programmed Cell Death Ligand 1 Might be Both Good and Bad Prognostic Factor in Adult T-Cell Leukemia/ Lymphoma, 57th annual meeting of the American society of hematology, 2015.12. |
| 30. |
Tochigi T, Aoki T, Kikushige Y, Kamimura T, Yamauchi T, Kato K, Takenaka K, Miyamoto T, Akashi K, Mobilization of Human Immature Hematopoietic Progenitors after Combinatory Use of Bortezomib and Immunomodulatory Drugs, 57th annual meeting of the American society of hematology, 2015.12. |
| 31. |
Minami M, Miyamoto T, Arita T, Kamimura T, Yuda J, Kikushige Y, Mori, Yasuo, Yoshimoto G, Kamezaki K, Kato K, Shiratsuchi M, Takenaka K, Iwasaki H, Yamasaki S, Muta T, Tanimoto K, Ogawa R, Eto T, Akashi K, Comparative Analysis of Tyrosine Kinase Inhibitors-Related Pulmonary Hypertension in the Patients Treated By Imatinib, Dasatinib and Nilotinib, 57th annual meeting of the American society of hematology, 2015.12. |
| 32. |
Yoshimoto G, Miyamoto T, Kato K, Mori Y, Kamezaki K, Takenaka K, Iwasaki H, Akashi K, Incidence and Differential Diagnosis of Human Herpes Virus-6 Associated Encephalitis/Myelitis in Allogeneic Stem Cell Transplantation That Mimics Calcineurin Inhibitor-Induced Pain Syndrome, 57th annual meeting of the American society of hematology, 2015.12. |
| 33. |
Sugio T, Kato K, Aoki T, Ota T, Saito N, Yoshida S, Kawano I, Henzan H, Takase K, Miyawaki K, Shima T, Takashima S, Yamauchi T, Mori Y, Yoshimoto G, Kamezaki K, Takenaka K, Kamimura T, Ohno Y, Eto T, Ogawa R, Iwasaki H, Miyamoto T, Akashi K, Prior Use of Mogamulizumab to Allogenic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-Versus-Host Disease, 57th annual meeting of the American society of hematology, 2015.12. |
| 34. |
Sugio T, Kato K, Henzan H, Aoki T, Ito Y, Saito N, Yoshida S, Kawano I, Ota T, Kadowaki M, Takase K, Miyawaki K, Yamauchi T, Shima T, Takashima S, Mori Y, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Kamimura T, Ohno Y, Eto T, Miyamoto T, Akashi K, Prior use of mogamulizumab to allo-HSCT induces severe acute GVHD (SETP), 第77回日本血液学会学術集会, 2015.10. |
| 35. |
Kato K, Adcetris treatment experience: From Asian perspectives, Takeda Symposium on Lymphoma ＆ Osteosarcoma, 2015.07. |
| 36. |
Kato K, Adcetris treatment experience: From Asian perspectives, Takeda Symposium on Lymphoma ＆ Osteosarcoma, 2015.07. |
| 37. |
Yoshimitsu M, Tanosaki R, Kato K, Ishida T, Choi I, Fukuda T, Takatsuka Y, Eto T, Uchida N, Moriuchi Y, Nagamura-Inoue T, Mori S , Sakamaki H, Atsuta Y, Utsunomiya A, Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group, 2015 BMT Tandem Meetings, 2015.02. |
| 38. |
Shimoji S, Hashimoto D, Kato K, Tujigiwa H, Akashi K, Teshima T, Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation, 2015 BMT Tandem Meetings, 2015.02. |
| 39. |
Kato K, Miyamoto T, Yonemoto K, Uchida N, Ogawa H, Fukuda T, Takahashi S, Ohashi K, Eto T, Nagamura-Inoue T, Sakamaki H, Morishima Y, Suzuki R, Atsuta Y, Akashi K, Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT, 56th annual meeting of the American society of hematology, 2014.12. |
| 40. |
Sonoko Shimoji, Koji Kato, Hidetsugu Tsujigiwa, Yoshihiro Eriguchi, Lifa Lee, Hidetaka Uryu, Shuichiro Takashima, Daigo Hashimoto, Koichi Akashi, Takanori Teshima, Graft-Versus-Host Disease Targets Ovary and Causes Infertility After Allogeneic Hematopoietic Stem Cell Transplantation
, 55th Annual Meeting and Exposition、American Society of Hematology, 2013.12. |
| 41. |
Harumi Kato, Dai Chihara, Koji Kato, Sung-Won Kim, Takehiko Mori, Masashi Sawa, Yuju Ohno, Hisako Hashimoto, Masayuki Hino, Koji Iwato, Takaaki Chou, Hisashi Sakamaki, Ritsuro Suzuki, Junji Suzumiya, Hepatitis B and C Virus Infections Are Not Associated With Worse Clinical Outcomes After Autologous Stem Cell Transplantation: On Behalf Of The Adult Lymphoma Working Group Of The Japan Society For Hematopoietic Cell Transplantation (JSHCT)
, 55th Annual Meeting and Exposition、American Society of Hematology, 2013.12. |
| 42. |
Koji Kato, Ilseung Cho, Atsushi Wake, Naokuni Uike, Shuichi Taniguchi, Yukiyoshi Moriuchi, Yasushi Miyazaki, Masayuki Hino, Koichi Akashi, Hisashi Sakamaki, Koji Kato, Ritsuro Suzuki, Takeharu Yamanaka, Atae Utsunomiya, Cord blood transplantation for adult T-cell leukemia/lymphoma (ATL): A retrospective analysis from the ATL working group of the JSHCT, 12th International conference on malignant lymphoma, 2013.06. |
| 43. |
Chihara D, Izutsu K, Kondo E, Sakai R, Mizuta S, Yokoyama K, Kaneko H, Kato K, Sakamaki H., Suzuki R, Suzumiya J, High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B-cell lymphoma: A retrospective from the adult lymphma working group of the JSHCT, 12th International conference on malignant lymphoma, 2013.06. |
| 44. |
Hidetaka Uryu, Hideyo Oka, Sonoko Shimoji, Yoshihiro Eriguchi, Shuichiro Takashima, Koji Kato, Koichi Akashi, Takanori Teshima, α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets, 2013 BMT Tandem Meetings, 2013.02. |
| 45. |
Koji Kato, et al, BK Virus Subtype III Is Associated with Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation, 2013 BMT Tandem Meetings, 2013.02. |
| 46. |
Junichiro Yuda, Koji Kato, Katsuto Takenaka, Masayasu Hayashi, Shingo Urata, Shuichiro Takashima, Yoshikane Kikushige, Kazuki Tanimoto, Hiromi Iwasaki, Toshihiro Miyamoto, Takanori Teshima, Koichi Akashi, Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome, 2013 BMT Tandem Meetings, 2013.02. |
| 47. |
Kazuhiro Mochizuki, Fang Xie, Shan He, Qing Tong, Yongnian Liu, Yajun Guo, Koji Kato, Hideo Yagita, Shin Mineishi, Yi Zhang, Identification of Previously Uncharacterized Delta 4-Positive Inflammatory Plasmacytoid Dendritic Cells That Play Important Roles in Eliciting Graft-Versus-Host Disease in Mice, 54th Annual Meeting and Exposition、American Society of Hematology, 2012.12. |
| 48. |
Shuichirou Takashima, Toshihiro Miyamoto, Tomohiko Kamimura, Shingo Urata, Yoshikane Kikushige, Yong Chong, Yoshikiyo Ito, Koji Kato, Kazuki Tanimoto, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, Koichi Akashi, Bortezomib, cyclophosphamide and dexamethasone (VCD) induction for symptomatic multiple myeloma
, 第74回日本血液学会学術集会総会, 2012.10. |
| 49. |
Oxidative phosphorylation by rapamycin augments generation of long-lived memory T cells . |
| 50. |
A possible role of recombinant human soluble thrombomodulin for a treatment of sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.. |
